| OBSCN altered in cohorts of …ALTERED_INderived27 of 27show fewer |
|---|
| → altered in cohorts of | Breast Invasive Carcinoma, NOS 806 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Endometrial Carcinoma 296 / 559 cases (53 %) · ssm · TCGA-UCEC · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | gdc | graph → |
| → altered in cohorts of | Skin Basal Cell Carcinoma 52 / 126 cases (41 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Cell Carcinoma 51 / 158 cases (32 %) · ssm · rcc_iatlas_immotion150_2018 | — | — | Renal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Melanoma 45 / 144 cases (31 %) · ssm · mel_dfci_2019 · largest of 3 cohorts | — | — | Melanoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Adrenal Cortical Carcinoma 27 / 90 cases (30 %) · ssm · acc_tcga | — | — | Adrenal Cortical Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 65 / 247 cases (26 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Skin Squamous Cell Carcinoma 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 99 / 469 cases (21 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 104 / 518 cases (20 %) · ssm · stes_tcga_pub | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 95 / 478 cases (20 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 84 / 429 cases (20 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Thymoma 24 / 124 cases (19 %) · ssm · TCGA-THYM | — | — | Thymoma | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 167 / 1,144 cases (15 %) · ssm · nsclc_tcga_broad_2016 · largest of 2 cohorts | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Adenocarcinoma 27 / 185 cases (15 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinoma 82 / 566 cases (14 %) · ssm · luad_tcga_pan_can_atlas_2018 · largest of 7 cohorts | — | — | Lung Adenocarcinoma | 7 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 126 / 1,015 cases (12 %) · ssm · crc_sysucc_2022 · largest of 4 cohorts | — | — | Colorectal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinoma 59 / 494 cases (12 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Glioma 70 / 629 cases (11 %) · ssm · difg_glass · largest of 3 cohorts | — | — | Diffuse Glioma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Squamous Cell Carcinoma 52 / 484 cases (11 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 47 / 474 cases (9.9 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cholangiocarcinoma 31 / 417 cases (7.4 %) · ssm · chol_icgc_2017 | — | — | Cholangiocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Invasive Breast Carcinoma 27 / 379 cases (7.1 %) · ssm · brca_mbcproject_2022 · largest of 2 cohorts | — | — | Invasive Breast Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cervical Squamous Cell Carcinoma 20 / 291 cases (6.9 %) · ssm · cesc_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Multiple Myeloma 64 / 961 cases (6.7 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Head and Neck Squamous Cell Carcinoma 34 / 515 cases (6.6 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Prostate Adenocarcinoma 53 / 1,013 cases (5.2 %) · ssm · prad_p1000 · largest of 2 cohorts | — | — | Prostate Adenocarcinoma | 2 | Observed | cbioportal | graph → |